You are here
STC BIOLOGICS, INC
UEI: N/A
# of Employees: 7
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
A Multi-Targeting Ligand Trap to Overcome resistance in BRAF Mutant Colorectal Cancer
Amount: $300,000.00DESCRIPTION provided by applicant Although targeted therapies have been developed to treat cancers with well elucidated molecular pathways these therapies still remain ineffective as innate or ac ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
IGF::OT::IGF SBIR PHASE II TOPIC 275, DEVELOPMENT OF GENERIC TRASTUZUMAB FOR THE TREATMENT OF BREAST CANCER.
Amount: $2,499,488.00The goal of this project is to develop STC101, a biosmilar Herceptin . Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
Not Available
Amount: $299,881.00The goal of this project is to develop STC trastuzumab, a generic version of Herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients w ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health